Beta Amyloid
Beta Amyloid inhibitors are compounds that target and prevent the formation or aggregation of beta-amyloid peptides, which are implicated in the pathogenesis of Alzheimer's disease. The accumulation of beta-amyloid plaques in the brain is a hallmark of the disease, leading to neuronal dysfunction and cognitive decline. Inhibitors of beta-amyloid aggregation are being explored as potential therapeutic agents to slow or prevent the progression of Alzheimer's disease. At CymitQuimica, we provide a range of beta-amyloid inhibitors to support your research in neurodegeneration, protein aggregation, and Alzheimer's therapy.
Found 240 products for "Beta Amyloid".
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
APP669-711
APP669-711 is a peptide fragment comprising amino acids 669 to 711 of the amyloid precursor protein (APP). This peptide serves as a biomarker in Alzheimer's disease (AD) research and is useful for diagnosing amyloid deposition in the brain.Formula:C210H325N57O61S2Molecular weight:4685.35229β-Amyloid (12-28)
CAS:Amyloid β-peptide fragment; minimum section required to bind to brain proteins.Formula:C89H135N25O25Purity:98%Color and Shape:SolidMolecular weight:1955.18RAGE antagonist peptide
CAS:RAGE antagonist blocks S100P/A4, HMGB-1; hinders glioma growth, metastasis; reduces PDAC cell growth, NF-κB activity; counters TDI effects in mice.Formula:C57H101N13O17SPurity:98%Color and Shape:SolidMolecular weight:1272.56Amyloid β-Protein (16-22)
CAS:Amyloid β-Protein (16-22) is a segment of the Aβ peptide.Formula:C43H64N8O10Molecular weight:853.02β-Amyloid (1-43)(human) TFA
β-Amyloid (1-43)(human) TFA exhibits greater aggregation tendencies and heightened toxicity compared to its well-established counterpart, Aβ1-42.Formula:C209H319F3N56O64SColor and Shape:SolidMolecular weight:4729.21β-Amyloid (1-40)
CAS:Amyloid β1-40 is one of the fragments generated after cleavage of the amyloid peptide precursor protein by β and γ secretases.Formula:C194H295N53O58SPurity:98%Color and Shape:SolidMolecular weight:4329.82γ-Secretase Modulators
CAS:gamma-Secretase Modulators serves as a useful treatment for Alzheimer's disease by inhibiting the production of Amyloid-β.Formula:C26H24F3N3O3Purity:98%Color and Shape:SolidMolecular weight:483.48Aducanumab
CAS:Aducanumab (BIIB037) is an IgG1 antibody targeting amyloid beta to treat Alzheimer's; it's brain-permeable.Purity:95% - 97.10%Color and Shape:Transparent LiquidMolecular weight:145.93 kDaAβ-IN-6
Aβ-IN-6 is an orally active compound exhibiting anti-inflammatory, antioxidant, and anti-oligomeric activities, with significant implications for Alzheimer'sFormula:C28H31N3O4Color and Shape:SolidMolecular weight:473.56β-Amyloid (33-40)
CAS:β-Amyloid (33-40) is a peptide comprising amino acids 33 to 40 of the beta-amyloid protein.Formula:C32H58N8O9SPurity:98%Color and Shape:SolidMolecular weight:730.92FITC-β-Ala-Amyloid β-Protein (1-42)
CAS:FITC-β-Ala-Amyloid β-Protein (1-42) is a polypeptide identified through peptide screening. This screening method predominantly utilizes immunoassays to gather active polypeptides and is used in studying protein interactions, conducting functional analyses, and screening antigen epitopes, with particular application in the research and development of active molecules.Formula:C227H327N57O66S2Color and Shape:SolidMolecular weight:4971.34251β-Amyloid (29-40)
CAS:β-Amyloid (29-40) is a fragment of Amyloid-β peptide.Alzheimer's beta amyloid peptide (29-40/42) C-terminal fragments have physical and chemical propertiesFormula:C49H88N12O13SPurity:98%Color and Shape:SolidMolecular weight:1085.36Biotinoyl tripeptide-1
CAS:Biotinoyl tripeptide-1 can produce hair follicles by promoting scalp micro-circulation and reduce follicle atrophy and aging.Formula:C24H38N8O6SPurity:98%Color and Shape:SolidMolecular weight:566.67Amyloid β-Protein (3-42)
CAS:Amyloid β-Protein (3-42), the precursor of Pyr peptide, serves as the foundation of the amyloid template block in Alzheimer's disease when modified toColor and Shape:Solidp-HTAA
CAS:p-HTAA is a pentamer thiopheneacetic acid labeling Aβ deposits, used in amyloid research.Formula:C24H16O4S5Purity:98.68% - 99.09%Color and Shape:Yellow SolidMolecular weight:528.71β-Amyloid (10-20)
CAS:Amyloid β-Protein (10-20) is a fragment of Amyloid-β peptide, maybe used in the research of neurological disease.Amyloid β protein fragment containing the α-Formula:C71H99N17O16Purity:98%Color and Shape:Lyophilized PowderMolecular weight:1446.65β-Amyloid (1-11)
CAS:Anionic interaction of Beta-amyloid (1-11) with Factor XII is suspected to cause massive activation of the C4 (complement 4) system in the cerebrospinal fluidFormula:C56H76N16O22Purity:98%Color and Shape:SolidMolecular weight:1325.3Biphenyl-3′,3,4,4′-tetrol
CAS:Biphenyl-3′,3,4,4′-tetrol (BPT) is a potent inhibitor of Aβ40 aggregation and can be utilized in research related to neurodegenerative diseases such as Alzheimer's.Formula:C12H10O4Color and Shape:SolidMolecular weight:218.21Aβ-IN-7
Aβ-IN-7 (compound 5a) acts as a potent inhibitor of Aβ aggregation, stabilizing Aβ monomers at 50 μM concentration to prevent them from forming larger oligomersFormula:C14H10N2SColor and Shape:SolidMolecular weight:238.31β-Amyloid (1-9)
CAS:This is an N-terminal fragment of beta amyloid.Formula:C42H60N14O17Purity:98%Color and Shape:SolidMolecular weight:1033.01β-Amyloid (10-35), amide
CAS:β-Amyloid (10-35), amide, is a chemical compound consisting of 26 amino acids, specifically residues 10-35 of the Aβ peptide.Formula:C133H205N35O36SPurity:98%Color and Shape:SolidMolecular weight:2902.33β-Amyloid (11-22)
CAS:β-Amyloid (11-22) is a peptide fragment of β-Amyloid.Beta-amyloid peptide (Abeta), the major constituent of amyloid plaques in the brains of Alzheimer’sFormula:C70H102N18O18Purity:98%Color and Shape:SolidMolecular weight:1483.67(Gln22)β-Amyloid (1-40) human
(Gln22)β-Amyloid (1-40) human is a peptide containing amyloid β-protein (Aβ), which can be utilized in Alzheimer's disease research.Formula:C194H296N54O57SMolecular weight:4326.16441(Met(O)35)-Amyloid β-Protein (1-42)
(Met(O)35)-Amyloid β-Protein (1-42) represents the oxidized form of Methionine 35 in Aβ42, capable of producing an oligomer size distribution akin to that ofFormula:C203H311N55O61SColor and Shape:SolidMolecular weight:4530.045-TAMRA-Amyloid β-Protein (1-40)
CAS:5-TAMRA-Amyloid β-Protein (1-40) is a TAMRA-labeled variant of Amyloid β-Protein (1-40), featuring an absorption/emission spectrum at 544/572 nm [1].Color and Shape:Solidβ-Amyloid (12-20)
CAS:β-Amyloid (12-20) is a peptide fragment of β-Amyloid.Thsis peptide contain the amino acid residues VFF at position (18-20), suggesting that this triad hasFormula:C57H83N15O11Purity:98%Color and Shape:SolidMolecular weight:1154.36LPYFD-NH2
CAS:neuroprotective peptide that binds to amyloid beta (Aβ)Formula:C33H44N6O8Purity:98%Color and Shape:SolidMolecular weight:652.74β-Amyloid (1-20)
CAS:This synthetic peptide consists of amino acids 1 to 20 of beta amyloid protein.Formula:C113H157N31O32Purity:98%Color and Shape:SolidMolecular weight:2461.7(Pyr3)-Amyloid β-Protein (3-42)
CAS:(Pyr3)-Amyloid β-Protein (3-42) is the predominant amyloid β peptide structure found deposited in the brains of individuals with Alzheimer's disease and Down syndrome. It is thought that (Pyr3)-Amyloid β-Protein (3-42) accumulates in the brain, leading to the formation of insoluble amyloid β-peptide deposits.Formula:C196H299N53O55SColor and Shape:SolidMolecular weight:4307.19498CHF-5022
CAS:CHF-5022 is a nonsteroidal anti-inflammatory drug that selectively inhibits the production of beta-amyloid protein (1-42) (ABETA42).Formula:C17H12F4O2Color and Shape:SolidMolecular weight:324.27β-Amyloid (22-40)
CAS:This synthetic peptide consists of amino acids 22 to 40 of beta amyloid protein.Formula:C78H135N21O26SPurity:98%Color and Shape:SolidMolecular weight:1815.1(Gln22)-Amyloid β-Protein (1-42)
CAS:(Gln22)-Amyloid β-Protein (1-42), a Dutch mutation (E22Q) variant of β-Amyloid (1-42), demonstrates increased fibrillogenic and pathogenic characteristics [1].Formula:C203H312N56O59SColor and Shape:SolidMolecular weight:4513.055-FAM-β-Amyloid (1-28)
5-FAM-β-Amyloid (1-28) is a fluorescently-labeled peptide corresponding to the first 28 amino acids of the β-Amyloid protein.Formula:C166H219N41O52Color and Shape:SolidMolecular weight:3620.76β-Amyloid (1-17)
CAS:This synthetic peptide consists of amino acids 1 to 17 of beta amyloid protein. This peptide can be employed in beta amyloid solubility studies.Formula:C90H130N28O29Purity:98%Color and Shape:SolidMolecular weight:2068.2FITC-β-Ala-β-Amyloid (25-35)
FITC-β-Ala-β-Amyloid (25-35) is a FITC-labeled fluorescent compound utilized in Alzheimer's disease research [1].Color and Shape:Odour SolidFITC-β-Ala-Amyloid β-Protein (1-42) (ammonium)
FITC-β-Ala-Amyloid β-Protein (1-42) (ammonium) is a FITC-labeled amyloid beta monomer, Alzheimer’s research, drug screening, and biomolecular studies.Formula:C227H330N58O66S2Color and Shape:SolidMolecular weight:4991.53β-Amyloid (13-27)
CAS:β-Amyloid (13-27) is a peptide consisting of amino acid of 13 to 27 of beta amyloid protein.Formula:C84H126N24O24Purity:98%Color and Shape:SolidMolecular weight:1856.05Nivegacetor
CAS:Nivegacetor(RG6289) is a selective and orally administrable γ-secretase regulator that can affect the production of amyloid-β in cerebrospinal fluid.Formula:C23H25F2N7O2Purity:99.84%Color and Shape:Yellow SolidMolecular weight:469.49β-Amyloid (1-16)
CAS:β-Amyloid (1-16) is an amyloidogenic protein fragment with a sequence derived from β-amyloid.Formula:C84H119N27O28Purity:98%Color and Shape:SolidMolecular weight:1955.04AZD4694 Precursor
CAS:AZD4694 Precursor used for synthesizing [18F]AZD4694, a high-affinity amyloid-β imaging agent.Formula:C22H25N3O7Color and Shape:SolidMolecular weight:443.45QSH peptide
CAS:The QSH peptide is a polypeptide that specifically binds to Aβ1-42, and is employed in the synthesis of siRNA delivery complexes. It is applicable in research related to Alzheimer's disease (AD).Formula:C62H95N21O18Color and Shape:SolidMolecular weight:1422.55Sabirnetug
CAS:Sabirnetug is a humanized IgG2κ monoclonal antibody that specifically targets the amyloid-β (A4) precursor protein.Color and Shape:LiquidSQ-3
SQ-3, a quinoline analogue, prefers α-syn (Ki=39.3nM) to Aβ (Ki=230nM), and [18F]SQ3 is a lead for α-syn probes. [1]Formula:C21H21FN2OColor and Shape:SolidMolecular weight:336.4Davunetide
CAS:Davunetide: neuroprotective 8-amino acid peptide, improves daily function in schizophrenia, boosts memory in mild cognitive impairment.Formula:C36H60N10O12Purity:98%Color and Shape:SolidMolecular weight:824.92BIBD-124
CAS:BIBD-124, with an IC50 value of 9.51 nM, effectively binds to amyloid beta (Aβ) plaques.Formula:C19H24FN3O3Color and Shape:SolidMolecular weight:361.41Chemerin-9 (149-157) TFA
Chemerin-9 (149-157) TFA is a peptide located at positions 149-157 of chemerin-9, acting as a ChemR23/CMKLR1 agonist.Formula:C56H67F3N10O15Purity:99.77%Color and Shape:White SolidMolecular weight:1177.18β-Amyloid (1-34)
CAS:This is a fragment of beta-amyloid peptide. It has amino acids 1 through 34.Formula:C170H253N47O52Purity:98%Color and Shape:SolidMolecular weight:3787.2β-Amyloid Protein Precursor 770 (135-155)
CAS:Beta-Amyloid Protein Precursor 770 (135-155)Aβ Protein Precursor 770 (135-155)Formula:C116H172N35O31S2Purity:98%Color and Shape:SolidMolecular weight:2617.96Davunetide acetate
Davunetide acetate is derived from activity-dependent neuroprotective protein existing in the mammalian CNS.Formula:C38H64N10O14Purity:99.52% - 99.78%Color and Shape:SolidMolecular weight:884.97GSK-3β inhibitor 27
GSK-3β inhibitor27 (Compound 1c) is a reversible, competitive inhibitor of GSK-3β with an IC50 value of 2.2 μM. It inhibits tau hyperphosphorylation and reduces Aβ protein aggregation, demonstrating metal chelation and neuroprotective potential. GSK-3β inhibitor27 is promising for research into neurodegenerative diseases, such as Alzheimer's disease.Formula:C16H17ClN4O2Color and Shape:SolidMolecular weight:332.79
